相似文献
1
Cancer therapy combination: green tea and a phosphodiesterase 5 inhibitor?
J Clin Invest. 2013 Feb;123(2):556-8. doi: 10.1172/JCI67589. Epub 2013 Jan 25.
2
67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis.
J Clin Invest. 2013 Feb;123(2):787-99. doi: 10.1172/JCI64768. Epub 2013 Jan 25.
3
Phosphodiesterase 5 inhibitor acts as a potent agent sensitizing acute myeloid leukemia cells to 67-kDa laminin receptor-dependent apoptosis.
FEBS Lett. 2013 Sep 17;587(18):3052-7. doi: 10.1016/j.febslet.2013.07.041. Epub 2013 Aug 1.
4
Vitamin A enhances antitumor effect of a green tea polyphenol on melanoma by upregulating the polyphenol sensing molecule 67-kDa laminin receptor.
PLoS One. 2010 Jun 10;5(6):e11051. doi: 10.1371/journal.pone.0011051.
5
Phosphodiesterase 5 Inhibitor Potentiates Epigallocatechin 3-O-Gallate-Induced Apoptotic Cell Death via Activation of the cGMP Signaling Pathway in Caco-2 Cells.
Curr Issues Mol Biol. 2022 Dec 9;44(12):6247-6256. doi: 10.3390/cimb44120426.
6
Green tea polyphenol EGCG sensing motif on the 67-kDa laminin receptor.
PLoS One. 2012;7(5):e37942. doi: 10.1371/journal.pone.0037942. Epub 2012 May 29.
7
Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cδ and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells.
Biochem J. 2012 Apr 15;443(2):525-34. doi: 10.1042/BJ20111837.
8
Epigallocatechin Gallate Induces Upregulation of LDL Receptor via the 67 kDa Laminin Receptor-Independent Pathway in HepG2 Cells.
Mol Nutr Food Res. 2020 Apr;64(7):e1901036. doi: 10.1002/mnfr.201901036. Epub 2020 Feb 5.
9
Attenuated migration by green tea extract (-)-epigallocatechin gallate (EGCG): involvement of 67 kDa laminin receptor internalization in macrophagic cells.
Food Funct. 2014 Aug;5(8):1915-9. doi: 10.1039/c4fo00143e.
10
Synergetic downregulation of 67 kDa laminin receptor by the green tea (Camellia sinensis) secondary plant compound epigallocatechin gallate: a new gateway in metastasis prevention?
BMC Complement Altern Med. 2012 Dec 18;12:258. doi: 10.1186/1472-6882-12-258.
引用本文的文献
1
Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis.
Int J Mol Sci. 2022 Dec 25;24(1):340. doi: 10.3390/ijms24010340.
2
()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes.
Oncol Res. 2021 Sep 7;28(7):763-778. doi: 10.3727/096504021X16135618512563. Epub 2021 Feb 17.
3
The inhibitory activity of gallic acid against DNA methylation: application of gallic acid on epigenetic therapy of human cancers.
Oncotarget. 2017 Dec 7;9(1):361-374. doi: 10.18632/oncotarget.23015. eCollection 2018 Jan 2.
4
(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.
Exp Ther Med. 2018 Jan;15(1):1105-1112. doi: 10.3892/etm.2017.5495. Epub 2017 Nov 13.
5
Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
Drug Des Devel Ther. 2016 Oct 31;10:3519-3528. doi: 10.2147/DDDT.S109589. eCollection 2016.
6
Phosphodiesterase sequence variants may predispose to prostate cancer.
Endocr Relat Cancer. 2015 Aug;22(4):519-30. doi: 10.1530/ERC-15-0134. Epub 2015 May 15.
7
Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition.
Int J Oncol. 2014 Oct;45(4):1391-400. doi: 10.3892/ijo.2014.2539. Epub 2014 Jul 8.
8
New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate.
Redox Biol. 2014 Jan 10;2:187-95. doi: 10.1016/j.redox.2013.12.022. eCollection 2014.
本文引用的文献
1
67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis.
J Clin Invest. 2013 Feb;123(2):787-99. doi: 10.1172/JCI64768. Epub 2013 Jan 25.
2
Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.
Cancer. 2013 Jan 15;119(2):363-70. doi: 10.1002/cncr.27719. Epub 2012 Jul 3.
3
Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cδ and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells.
Biochem J. 2012 Apr 15;443(2):525-34. doi: 10.1042/BJ20111837.
4
Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1.
Cancer Prev Res (Phila). 2011 Sep;4(9):1366-77. doi: 10.1158/1940-6207.CAPR-11-0301. Epub 2011 Jul 12.
5
Pharmacokinetic and chemoprevention studies on tea in humans.
Pharmacol Res. 2011 Aug;64(2):105-12. doi: 10.1016/j.phrs.2011.05.007. Epub 2011 May 20.
6
Mechanistic issues concerning cancer prevention by tea catechins.
Mol Nutr Food Res. 2011 Jun;55(6):819-31. doi: 10.1002/mnfr.201100036. Epub 2011 Apr 29.
7
Tea and cancer prevention: epidemiological studies.
Pharmacol Res. 2011 Aug;64(2):123-35. doi: 10.1016/j.phrs.2011.03.002. Epub 2011 Mar 23.
8
TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor.
J Immunol. 2010 Jul 1;185(1):33-45. doi: 10.4049/jimmunol.0903742. Epub 2010 May 28.
9
Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro.
Carcinogenesis. 2010 May;31(5):902-10. doi: 10.1093/carcin/bgq039. Epub 2010 Feb 16.
10
Multiple functions of the 37/67-kd laminin receptor make it a suitable target for novel cancer gene therapy.
Mol Ther. 2010 Jan;18(1):63-74. doi: 10.1038/mt.2009.199. Epub 2009 Sep 1.
Zotero 插件